AI assistant
Microbot Medical Inc. — Director's Dealing 2013
Jun 8, 2013
33819_dirs_2013-06-07_1897321d-8a0c-4af2-b7cd-e4ed35a21b21.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2012-06-01
Reporting Person: TSUKAMOTO ANN (EVP, Research and Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-06-01 | Common Stock | F | 12448 | $1.76 | Disposed | 148646 | Direct |
| 2013-06-06 | Common Stock | A | 280000 | $0.00 | Acquired | 428646 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3643 | Indirect |
| Common Stock | 16791 | Indirect |
Footnotes
F1: This is recorded as a Code F disposition because the shares were used by the reporting person to pay a tax liability incurred by her from the delivery of shares incident to the vesting of restricted stock units.
F2: Restricted stock units, with 1/4 vesting on June 6, 2014, June 6, 2015, June 6, 2016, and June 6, 2017.
F3: Includes (1) 280,000 restricted stock units, with 70,000 vesting on each of June 6, 2014, June 6, 2015, June 6, 2016, and June 6, 2017; and (2) 86,666 restricted stock units, with 43,333 vesting on each of January 27, 2014 and January 27, 2015.
F4: 3,643 shares held in trust as to which Dr. Tsukamoto disclaims beneficial ownership.
F5: Shares held in 401(k) account in accordance with issuer's employer-match policies.